INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 168 filers reported holding INSMED INC in Q1 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,109,664 | +53.3% | 123,155 | +28.1% | 0.00% | +33.3% |
| Q2 2023 | $2,028,448 | -68.7% | 96,135 | -74.7% | 0.00% | -66.7% |
| Q1 2023 | $6,472,095 | -38.9% | 379,595 | -28.4% | 0.01% | -43.8% |
| Q4 2022 | $10,593,816 | -98.4% | 530,221 | +1500.3% | 0.02% | +1500.0% |
| Q2 2022 | $653,383,000 | -63.4% | 33,133 | -56.4% | 0.00% | -50.0% |
| Q1 2022 | $1,783,932,000 | -8.0% | 75,912 | +6.6% | 0.00% | -33.3% |
| Q4 2021 | $1,939,325,000 | +226.7% | 71,194 | +230.3% | 0.00% | +200.0% |
| Q3 2021 | $593,625,000 | -44.0% | 21,555 | -42.1% | 0.00% | 0.0% |
| Q2 2021 | $1,059,452,000 | +141.2% | 37,226 | +188.7% | 0.00% | 0.0% |
| Q1 2021 | $439,204,000 | -13.2% | 12,895 | -15.1% | 0.00% | 0.0% |
| Q4 2020 | $505,775,000 | -34.0% | 15,193 | -36.3% | 0.00% | 0.0% |
| Q3 2020 | $766,250,000 | +142.5% | 23,841 | +107.8% | 0.00% | 0.0% |
| Q2 2020 | $315,966,000 | -56.2% | 11,473 | -74.5% | 0.00% | 0.0% |
| Q1 2020 | $720,677,000 | +136.9% | 44,958 | +252.9% | 0.00% | 0.0% |
| Q4 2019 | $304,207,000 | -82.9% | 12,739 | -23.2% | 0.00% | -66.7% |
| Q3 2019 | $1,776,912,000 | +573.0% | 16,582 | +60.8% | 0.00% | +200.0% |
| Q2 2019 | $264,013,000 | -79.8% | 10,313 | -77.1% | 0.00% | -66.7% |
| Q1 2019 | $1,306,609,000 | +5321.4% | 44,947 | +2346.8% | 0.00% | – |
| Q4 2018 | $24,101,000 | -93.9% | 1,837 | -59.6% | 0.00% | – |
| Q3 2018 | $392,126,000 | +288.0% | 4,543 | +6.3% | 0.00% | – |
| Q2 2018 | $101,056,000 | -83.2% | 4,273 | -84.0% | 0.00% | -100.0% |
| Q1 2018 | $602,252,000 | +19.4% | 26,743 | +65.3% | 0.00% | 0.0% |
| Q4 2017 | $504,586,000 | +93.3% | 16,183 | +93.5% | 0.00% | 0.0% |
| Q3 2017 | $261,072,000 | +102.9% | 8,365 | +11.6% | 0.00% | – |
| Q2 2017 | $128,666,000 | +651.3% | 7,498 | +666.7% | 0.00% | – |
| Q1 2017 | $17,125,000 | -21.3% | 978 | -40.5% | 0.00% | – |
| Q4 2016 | $21,750,000 | -67.8% | 1,644 | -64.7% | 0.00% | – |
| Q3 2016 | $67,562,000 | +184.6% | 4,653 | +93.2% | 0.00% | – |
| Q2 2016 | $23,743,000 | -90.0% | 2,408 | -81.6% | 0.00% | -100.0% |
| Q4 2015 | $237,474,000 | +2.1% | 13,084 | +4.4% | 0.00% | 0.0% |
| Q3 2015 | $232,664,000 | +86.2% | 12,529 | +144.9% | 0.00% | – |
| Q2 2015 | $124,933,000 | +412.1% | 5,116 | +336.1% | 0.00% | – |
| Q1 2015 | $24,398,000 | -40.4% | 1,173 | -62.6% | 0.00% | – |
| Q3 2014 | $40,925,000 | +29342.4% | 3,136 | +31260.0% | 0.00% | – |
| Q1 2014 | $139,000 | -98.2% | 10 | -97.8% | 0.00% | – |
| Q4 2013 | $7,633,000 | -94.6% | 449 | -96.2% | 0.00% | – |
| Q2 2013 | $141,989,000 | – | 11,872 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |